Early adopters have hailed the RETeval Complete as being useful for ophthalmologists treatinf children with uncertain visual potential.
Here are four highlights:
1. RETeval Complete is one of the first non-mydriatic, noninvasive hand-held, full function ISCEV protocol-compliant visual electrophysiology device performing both flash Electroetinogram and flash visual evoked potential testing using skin or corneal electrodes.
2. The patented device is FDA-cleared, CE-marked and currently approved for use in 73 countries around the world.
3. The RETeval is especially helpful in young children with nystagmus and a normal fundus, who may have Leber's congenital amaurosis, congenital stationary night blindness or achromatopsia.
4. LKC Technologies will exhibit the RETeval Complete at the American Association of Pediatric Ophthalmology annual meeting in Vancouver in Canada from April 6 to April 10.